Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide.
作者:
主题词
成年人(Adult);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);化学疗法, 辅助(Chemotherapy, Adjuvant);环磷酰胺(Cyclophosphamide);数据说明, 统计(Data Interpretation, Statistical);表柔比星(Epirubicin);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);中年人(Middle Aged);骨髓增生异常综合征(Myelodysplastic Syndromes);随机对照试验(主题)(Randomized Controlled Trials as Topic);危险因素(Risk Factors)
DOI
10.1200/JCO.2005.05.029
PMID
15961765
发布时间
2013-11-21
- 浏览59

Journal of clinical oncology
4179-91页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文